BofA Global Research raises AbbVie price target to $276 from $234
ABBV•Related News
NYSE American halts China Pharma Holdings at $0.78
CPHI•
BofA Global Research cuts Pfizer price target to $26 from $27
PFE•
Nasdaq trade halt continues for PTNM, reason not available at 9:31 a.m.
PTNM•
Quest Diagnostics Hair Test Positivity Jumps to 19.1% in 2025
DGX•
Nasdaq pauses trading in Nuvve Holdings at 9:41 a.m. on volatility
NVVE•